Human leukemic HL-60 cells are an established model for studies of differentiation induction. Retinoic acid (RA), 2 x 10-6M, was used to induce terminal differentiation, assayed as nitroblue tetrazol reduction (NBT) and expression of monocytic surface antigens, which were detected by monoclonal antibody Leu M3. In addition, transferrin receptor expression and the number of S + G2 + M-phase cells were determined. With a 12-hr RA incubation, only a decrease of transferrin receptor expression was found, with no change in other parameters. At least 96 hr RA incubation was necessary to induce terminal differentiation, with most cells being positive for NBT and M3. Cells induced with RA for 12 hr and subsequently recultured in liquid culture gradually expressed the differentiated phenotype and lost transferrin receptor expression. The number of S + G2 + M-phase cells in the cultures decreased drastically. After 12 hr RA exposure and 120 hr reculture without RA, the differentiation profile was comparable to that of cells that had been induced with RA for 96 hr. In reculture for up to 120 hr there was no evidence of loss of viability or regrowth of possibly residual undifferentiated cells. From these studies, we conclude that HL-60 cells become committed to terminal differentiation after half a generation-time exposure to RA and remain committed for at least six generation times.
Introduction
Cancer can be viewed as a disorder of gene expression resulting in uncoupling of the control of cellular proliferation and differentiation. In this context, neoplastic cell lines that can be induced to terminal differentiation can be used to study the modification of this process, possibly providing new options for the treatment of leukemias.
Normal hematopoietic cell development is depicted as proceeding from a morphologically immature stem cell with unlimited self-renewal capacity to progenitor cells committed to a specific lineage with limited self-renewal capacity and terminally differentiated lineage-specific cells with restricted or no-self-renewal capacity. The strategy of differentiation induction in tumors is based on the assumption that by inducing differentiation, downregulation and eventually loss of self-renewal capacity of the malignant clone is achievable.
The human myeloid leukemic cell line HL-60 (1) is a bipotential cell that can be differentiated by various agents either to the monocytic or granulocytic pathway (2 of differentiation, which are not necessarily coupled (3) (4) (5) , and by using clonal assays after exposing cells to dimethylsulfoxide and retinoic acid (6, 7) . The present study takes a different experimental approach by using whole cell populations in liquid culture as the differentiation target. In addition to the NBT-assay, surface antigen expression of transferrin receptor (TfR) and Leu M3 (M3) were used to monitor cellular differentiation.
Experimental Procedures
Cell Line, Culture Conditions, and Viability HL-60 cells were obtained from the American Tissue Culture Collection and routinely passaged at a density of 2 x 105 cells/mL in RPMI 1640 (Seromed-Biochrom, Berlin, FRG), 10% (v/v) preselected fetal calf serum (FCS) (Gibco/BRL, Eggenstein,, FRG), 100 U/mL penicillin G (Seromed) and 100 mg/L streptomycin (Seromed) in a 5% CO2 automatically controlled atmosphere. The doubling time of the cells in the experiments was between 20 and 22 hr.
The cell suspension was incubated with 0.1% trypan blue (Sigma chemie, Deisenhofen, FRG) in 0.9% NaCl for 10 min. Trypan blue exclusion was determined by scoring 200 cells using a light microscope.
NBT Assay
Using a commercially available nitroblue tetrazole (NBT) assay (Sigma), 0.1-mL cell suspension at a den-sity of 106 cells/mL were mixed with 0.2 mL NBT solution and 0.1 mL stimulant and incubated for 25 min at 37°C. Subsequently, cytocentrifuge slides were prepared. NBT reduction to blue-black formazan (NBT positive) after stimulation indicates oxidative bursts characteristic for mature granulocytic or monocytic cells. NBT-positive cells were determined by scoring 200 cells under a light microscope.
S-Phase Assignment
The pellet obtained from washing 106 cells in RPMI 1640 was resuspended in 0.6 mL staining solution (0.1% Na-citrat, 50 ,ug/mL propidium iodide, 0.1% Triton X-100, 0.05 mg/mL RNase) and incubated 30 min at 37°C. Relative DNA content was determined by measuring propidium iodide fluorescence at 380 nm using a FACScan (Becton-Dickinson, Heidelberg, FRG), and cells were assigned to S + G2 + M-phase according to relative DNA content.
Leu M3 and Transferrin Receptor Expression
Monoclonal antibodies anti-Leu M3 fluorescein isothiocyanate conjugate (FITC) (Becton-Dickinson, specificity: human monocyte/macrophage antigen) and antitransferrin receptor antibody FITC (Becton-Dickinson, specificity: human transferrin receptor) were used. After washing, 106 cells were resuspended in 50 ,uL RPMI with 10% FCS and incubated with 20 pL of the respective antibody for 30 min on ice. Cells were then washed with phosphate-buffered saline (PBS) resuspended in 500 ,uL PBS, and the percentage of fluorescein-staining cells was measured using a FACScan. Controls for nonspecific staining were done using an irrelevant antibody, goat-anti-mouse (GAM-FITC, Becton-Dickinson).
Experimental Design HL-60 cells at a density of 2.5 x 105 cells/mL were incubated in liquid culture with 2 x 10-6M cis-retinoic acid (RA) for 12, 24, and 96 hr (incubation time). Controls were cultured without RA. Cells were removed from the culture and assayed for viability, scored for NBT reduction, and assayed for TfR expression, M3 expression, and DNA content. The remainder of the cells were washed three times in FCS-containing culture medium and reseeded in liquid culture at initial density without RA. At 24, 48, 72, 96, and 120 hr (reculture time), aliquots were removed from the cultures and cells assayed as described above. All experiments were done in triplicate; results are given as medians.
Results
The present study using HL-60 cells addressed the question of commitment to differentiation after exposure to RA. In control cultures, 68 to 74% of cells were TfR positive, 41 to 46% were in S + G2 + M-phase, 0 to 0.8% were NBT positive, and 3 to 5% were M3 positive. Viability was 89 to 91%. No difference in these parameters was apparent after different times (0-120 hr) in liquid culture without RA.
Reculture of HL-60 Cells after a 12-Hour RA Incubation Cells were incubated with RA for 12 hr and recultured without RA for 24 to 120 hr (Fig. 1) 
Reculture of HL-60 Cells after a 24-Hour RA Incubation
Reculture after a 24-hr RA incubation resulted in progressive differentiation with an increase of M3 positive cells to 52.0% (SD, 13.9) and NBT positive to 68.8% (SD, 13.6) of cells. TfR-positive cells remained low, between 1.7 and 4.6%. S + G2 + M-phase cells started to decrease at 24 hr reculture time and reached 11.3% (SD, 4.8) at 120 hr.
Reculture of HL-60 Cells after a 96-Hour RA Incubation
After a 72-hr reculture, viability had decreased significantly to 59.5% (SD, 21.9), and at 120 hr, viability had -further decreased to 40.0% (SD, 17.0) (Fig. 2) . The number of S + G2 + M-phase cells remained low, be- (6) , suggested that reversible losses of selfrenewal capacity precede irreversible phenotypic differentiation. The limitation of the experimental approach in both cases is that it does not allow for detection of regrowth of relatively few cells in liquid culture after prolonged reculture without inducer. From both types of experiments, it was concluded that commitment to differentiation occurred in HL-60 cells. Further analysis using semisolid cultures in the present experimental setting is necessary to determine the correlation of changes in clonal growth with the parameters reported here. If leukemic cells in vivo can be committed to differentiation with differentiation inducers, a novel therapeutic modality for the treatment of leukemias becomes available.
